Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor
Ping Chi, Li-Xuan Qin, Bastien Nguyen, et al.
JCO Oncology Advances
|
May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
The Journal of Clinical Investigation
|
December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models
Dezhi Li, Ke Geng, Yuan Hao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 10, 2024
Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms
Christopher M Heaphy, Simmi Patel, Katelyn Smith, et al.
Nature Communications
|
June 15, 2022
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Benjamin A Nacev, Francisco Sanchez-Vega, Shaleigh A Smith, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor
Ping Chi, Li-Xuan Qin, Bastien Nguyen, et al.
JCO Oncology Advances
|
May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
The Journal of Clinical Investigation
|
December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models
Dezhi Li, Ke Geng, Yuan Hao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 10, 2024
Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms
Christopher M Heaphy, Simmi Patel, Katelyn Smith, et al.
Nature Communications
|
June 15, 2022
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Benjamin A Nacev, Francisco Sanchez-Vega, Shaleigh A Smith, et al.
Page
of 4